Paralemmin-3 contributes to lipopolysaccharide-induced inflammatory response and is involved in lipopolysaccharide-Toll-like receptor-4 signaling in alveolar macrophages-Reference-Cited by-同舟云学术

Paralemmin-3 contributes to lipopolysaccharide-induced inflammatory response and is involved in lipopolysaccharide-Toll-like receptor-4 signaling in alveolar macrophages

Published:2017-09-28 Issue: Volume: Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Chen Xu-Xin¹,Tang Lu²,Fu Yu-Mei³,Wang Yi⁴,Han Zhi-Hai¹,Meng Ji-Guang¹

Affiliation:

1. Department of Respiratory Medicine, Navy General Hospital of the PLA, Beijing 100037, P.R. China

2. Department of Neurology, The First Hospital of Changsha, Changsha, Hunan 430100, P.R. China

3. Department of Emergency, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China

4. Department of Respiratory Medicine, The Sixth People's Hospital of Jinan City Affiliated to Jining Medical College, Jinan, Shandong 250200, P.R. China

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of Lian Hua Qing Wen capsules regulates the inflammatory response caused by M1 macrophage based on cellular experiments and computer simulations;Acta Tropica;2024-09

2. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma;Translational Oncology;2024-08

3. S100A9-/- alleviates LPS-induced acute lung injury by regulating M1 macrophage polarization and inhibiting pyroptosis via the TLR4/MyD88/NFκB signaling axis;Biomedicine & Pharmacotherapy;2024-03

4. Paralemmin-3 augments lipopolysaccharide-induced acute lung injury with M1 macrophage polarization via the notch signaling pathway;Respiratory Physiology & Neurobiology;2024-02

5. Fuzhengjiedu formula exerts protective effect against LPS-induced acute lung injury via gut-lung axis;Phytomedicine;2024-01